SEC 13F Intelligence

Managers / Q4 2019 · view latest →

Taconic Capital Advisors LP

CIK 0001390113 · 280 PARK AVENUE, 5TH FLOOR, NEW YORK, NY, 10017 · 212-209-3100

Reported Value
$2.9B
Q4 2019
Positions
47
includes revealed positions
Filings on Record
154
2019–present window
Filed
Feb 14, 2020
original filing

Summary

Taconic Capital Advisors LP reported $2.9B in U.S.-listed holdings across 47 positions for Q4 2019.

The portfolio is heavily concentrated: CELG alone accounts for 25.5% of reported value.

Compared with Q3 2019, the fund opened 23 new positions and exited 20.

Portfolio Metrics

Turnover
+22.4%
vs prior filed quarter
Top-10 Concentration
+44.1%
share of reported value
Largest Position
+25.5%
Celgene
New / Exited
23 / 20
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.0BQ4 ’18Q1 ’19: $2.1BQ2 ’19: $1.2BQ3 ’19: $995MQ4 ’19: $2.9BQ4 ’19Q1 ’20: $947MQ2 ’20: $1.5BQ3 ’20: $1.8BQ4 ’20: $2.2BQ4 ’20Q1 ’21: $2.8BQ2 ’21: $3.2BQ3 ’21: $3.6BQ4 ’21: $3.3BQ4 ’21Q1 ’22: $4.8BQ2 ’22: $3.3BQ3 ’22: $3.3BQ4 ’22: $2.4BQ4 ’22Q1 ’23: $1.4BQ2 ’23: $1.8BQ3 ’23: $1.5BQ4 ’23: $742MQ4 ’23Q1 ’24: $381MQ2 ’24: $671MQ3 ’24: $292MQ4 ’24: $810MQ4 ’24Q1 ’25: $509MQ2 ’25: $5.2BQ3 ’25: $482MQ4 ’25: $662MQ4 ’25Q1 ’26: $229Mfilingsflow.com

Portfolio Composition

By security type
ETP: 46.6%Common Stock: 46.2%ADR: 3.7%Other: 3.1%REIT: 0.3%US DOMESTIC: 0.2%
  • ETP · 46.6% · $1.4B
  • Common Stock · 46.2% · $1.3B
  • ADR · 3.7% · $108M
  • Other · 3.1% · $89M
  • REIT · 0.3% · $8M
  • US DOMESTIC · 0.2% · $5M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
CELGCELGENE CORPREVEALEDNEW+8.05M8.05M+$770M$770M
BABAALIBABA GROUP HLDG LTDNEW+500.0K500.0K+$106M$106M
MSFTMICROSOFT CORPNEW+550.0K550.0K+$87M$87M
JNJJOHNSON & JOHNSONNEW+500.0K500.0K+$73M$73M
NKENIKE INCNEW+600.0K600.0K+$61M$61M
DISDISNEY WALT CONEW+400.0K400.0K+$58M$58M
PYPLPAYPAL HLDGS INCNEW+480.0K480.0K+$52M$52M
BRK/BBERKSHIRE HATHAWAY INC DELNEW+135.0K135.0K+$31M$31M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2019REVEALED

37 positions
#IssuerClass% PortfolioValueShares
1CELGCELGENE CORPREVEALEDhistory →COM25.48%$742M7.75M
2BABAALIBABA GROUP HLDG LTDhistory →SPONSORED ADS3.64%$106M500.0K
3MSFTMICROSOFT CORPhistory →COM2.98%$87M550.0K
4JNJJOHNSON & JOHNSONhistory →COM2.51%$73M500.0K
5NKENIKE INChistory →CL B2.09%$61M600.0K
6DISDISNEY WALT COhistory →COM DISNEY1.99%$58M400.0K
7PYPLPAYPAL HLDGS INChistory →COM1.78%$52M480.0K
8ASSURED GUARANTY LTDCOM1.52%$44M900.0K
9BRK/BBERKSHIRE HATHAWAY INC DELhistory →CL B NEW1.05%$31M135.0K
10CVSCVS HEALTH CORPhistory →COM1.05%$30M410.0K
11HDHOME DEPOT INChistory →COM1.04%$30M138.0K
12UTXZUNITED TECHNOLOGIES CORPhistory →COM0.69%$20M135.0K
13GENNORTONLIFELOCK INChistory →COM0.64%$19M725.0K
14QCOMQUALCOMM INChistory →COM0.52%$15M170.0K
15NXP SEMICONDUCTORS N VCOM0.49%$14M111.0K
16UNHUNITEDHEALTH GROUP INChistory →COM0.43%$13M43.0K
17QIAGEN NVSHS NEW0.41%$12M350.0K
18SPDR S&P 500 ETF TRTR UNIT0.33%$10M29.5K
19TMUST MOBILE US INCCOM0.32%$9M120.5K
20CNCCENTENE CORP DELCOM0.31%$9M145.0K
21BIIBBIOGEN INCCOM0.31%$9M30.0K
22GENERAL ELECTRIC COCOM0.30%$9M773.4K
23FQIDIGITAL RLTY TR INCCOM0.29%$8M70.7K
24MPCMARATHON PETE CORPCOM0.28%$8M135.0K
25GNWGENWORTH FINL INCCOM CL A0.25%$7M1.63M
26MYLAN N VSHS EURO0.24%$7M350.0K
27CCOCLEAR CHANNEL OUTDOOR HLDGSCOM0.22%$6M2.23M
28MOHMOLINA HEALTHCARE INCCOM0.14%$4M30.0K
29ALXNALEXION PHARMACEUTICALS INCCOM0.11%$3M30.0K
30TEVA PHARMACEUTICAL FIN LLCDBCV 0.250% 2/00.10%$3M3.17M
31PTONPELOTON INTERACTIVE INCCL A COM0.07%$2M72.4K
32OIBR/USDOI S ASPONSORED ADR NE0.06%$2M1.90M
33NVSTENVISTA HLDGS CORPCOM0.05%$1M50.0K
34FTI CONSULTING INCNOTE 2.000% 8/10.04%$1M1.00M
35PURE STORAGE INCNOTE 0.125% 4/10.03%$1M1.00M
36ARANTERO RES CORPCOM0.03%$855,000300.0K
37AVYAUSDAVAYA HLDGS CORPCOM0.00%$013

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$229M15May 15, 2026RESTATEMENTchanges · EDGAR ↗
Q4 2025REVEALED$662M43Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025REVEALED$482M45Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025REVEALED$5.2B115Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025REVEALED$509M60May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024REVEALED$810M71Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024REVEALED$292M96Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024REVEALED$671M95Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$381M99May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$742M130Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$1.5B163Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$1.8B213Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.4B274May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$2.4B477Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$3.3B646Nov 14, 2022RESTATEMENTchanges · EDGAR ↗
Q2 2022REVEALED$3.3B704Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022REVEALED$4.8B586May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021REVEALED$3.3B569Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021REVEALED$3.6B483Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021REVEALED$3.2B478Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$2.8B367May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020REVEALED$2.2B201Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.8B123Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.5B47Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$947M43May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019REVEALED$2.9B47Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$995M37Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.2B41Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019REVEALED$2.1B51May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.0B48Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • Taconic Capital Advisors UK LLP028-12491
  • Taconic Capital Advisors (Hong Kong) Ltd028-15064

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.